65 /100
HIGH RISK
Score updated May 30, 2026

ORBS — Eightco Holdings Inc. Dilution Risk Tracker

Track ORBS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ORBS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
95
📊 Float Risk
17
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
61%
🔄 Reverse Split 70%
• 50-day avg $0.93 below $1 exchange minimum
• Only 3 months cash — financial pressure
💰 Capital Raise 55%
• Critical: only 2.7 months cash remaining
📉 Score Deterioration 50%
• Score rose 45 points recently (worsening)
• Score in HIGH risk zone (65/100)
🔔 Track ORBS — Get forecast alerts →

💹 Market Data

Market Cap$359.42M
Shares Outstanding388.01M
Float269.57M
Cash$40.16M
Debt$9.12M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 90.40M shares
#1 Coinfund Management LLC 17.12M shares
#2 Mozayyx Management LLC 16.44M shares
#3 Discovery Capital Management, LLC 14.87M shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest21.20M
Days to Cover1.6
% of Float7.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2025
4 INSIDER TRANSACTION Mar 18, 2026
3 FORM3 Mar 18, 2026
4 INSIDER TRANSACTION Mar 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

Track ORBS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ORBS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ORBS
📊 ORBS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ORBS Signal Convergence & Dark Pool Activity — StonkWhisper 📄 ORBS Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.